204 related articles for article (PubMed ID: 15961168)
1. Development and evaluation of Varicella zoster virus ELISA for oral fluid suitable for epidemiological studies.
Talukder Y; Gopal R; Andrews N; Glenn M; Breuer J; Brown D
J Virol Methods; 2005 Sep; 128(1-2):162-7. PubMed ID: 15961168
[TBL] [Abstract][Full Text] [Related]
2. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.
Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD
J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506
[TBL] [Abstract][Full Text] [Related]
3. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
Sauerbrei A; Wutzler P
Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
[TBL] [Abstract][Full Text] [Related]
4. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
[TBL] [Abstract][Full Text] [Related]
5. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
[TBL] [Abstract][Full Text] [Related]
6. A laboratory study of age-related varicella incidence and prevalence in the Czech Socialist Republic.
Trlifajová J; Svandová E; Pokorný J; Pokorný J
Acta Virol; 1989 Mar; 33(2):183-7. PubMed ID: 2569816
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent assay for detection of antibodies to varicella zoster virus.
Goldberg RD; Sarov I
Isr J Med Sci; 1980 Feb; 16(2):111-7. PubMed ID: 6245042
[TBL] [Abstract][Full Text] [Related]
9. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia.
Nokes DJ; Enquselassie F; Nigatu W; Vyse AJ; Cohen BJ; Brown DW; Cutts FT
Bull World Health Organ; 2001; 79(7):588-95. PubMed ID: 11477961
[TBL] [Abstract][Full Text] [Related]
10. Rapid assay for antibodies to Varicella-Zoster virus (VZV) using a VZV-HEM preparation.
Trlifajová J; Kyselová M; Brůcková M; Svandová E
J Hyg Epidemiol Microbiol Immunol; 1986; 30(2):171-6. PubMed ID: 3013988
[TBL] [Abstract][Full Text] [Related]
11. History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.
Wrensch M; Weinberg A; Wiencke J; Miike R; Sison J; Wiemels J; Barger G; DeLorenze G; Aldape K; Kelsey K
Am J Epidemiol; 2005 May; 161(10):929-38. PubMed ID: 15870157
[TBL] [Abstract][Full Text] [Related]
12. [Varicella-zoster virus seroprevalence in children between 0-15 years old].
Savaş S; Dallar Y; Arikan I; Onde U
Mikrobiyol Bul; 2004; 38(1-2):69-75. PubMed ID: 15293904
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.
Heininger U; Desgrandchamps D; Schaad UB
Vaccine; 2006 Apr; 24(16):3258-60. PubMed ID: 16459000
[TBL] [Abstract][Full Text] [Related]
14. Perspective on live varicella vaccine.
Gershon AA; Katz SL
J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
[TBL] [Abstract][Full Text] [Related]
15. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
Sauerbrei A; Wutzler P
J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
[TBL] [Abstract][Full Text] [Related]
16. Comparison of fifteen commercial assays for detecting Varicella Zoster virus IgG with reference to a time resolved fluorescence immunoassay (TRFIA) and the performance of two commercial assays for screening sera from immunocompromised individuals.
Chris Maple PA; Gunn A; Sellwood J; Brown DW; Gray JJ
J Virol Methods; 2009 Feb; 155(2):143-9. PubMed ID: 18996415
[TBL] [Abstract][Full Text] [Related]
17. Varicella seroprevalence in Turkish population in Cyprus.
Kurugol Z; Koturoglu G; Aksit S; Ozacar T
Acta Paediatr; 2007 Jun; 96(6):861-3. PubMed ID: 17465984
[TBL] [Abstract][Full Text] [Related]
18. Isolation of varicella-zoster virus from vesicles in children with varicella.
Ozaki T; Kajita Y; Namazue J; Yamanishi K
J Med Virol; 1996 Apr; 48(4):326-8. PubMed ID: 8699164
[TBL] [Abstract][Full Text] [Related]
19. Varicella zoster seroprevalence in children less than 5 years old.
Ozkan S; Maral I; Ilhan F; Aycan S; Cirak MY; Beyazova U; Aygun R
J Trop Pediatr; 2005 Jun; 51(3):141-4. PubMed ID: 15831668
[TBL] [Abstract][Full Text] [Related]
20. Immunity to varicella zoster virus in young Israeli adults.
Avrahami-Heller Y; Cohen D; Orr N; Slepon R; Ashkenazi I; Danon YL
Isr Med Assoc J; 2000 Mar; 2(3):196-9. PubMed ID: 10774265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]